Skip to main content
. 2018 May 10;2018(5):CD012069. doi: 10.1002/14651858.CD012069.pub2

Li 2011.

Methods An 8‐week, randomised, double‐blind, parallel study with 2 interventions:
  1. Methylphenidate

  2. Ningdong granule

Participants Number of participants screened: 136
Number of participants included: 72
Number of participants randomised to methylphenidate: 36
Number followed up: 34
Number of withdrawals: 2
Diagnosis of ADHD: DSM‐IV (subtype: not stated)
Age: mean 9.2, range 3‐13 years old
IQ: almost all above 70
Sex: 23 males, 13 females
Methylphenidate‐naïve: not stated
Ethnicity: not stated
Country: China
Comorbidity: not stated
Comedication: not stated
Sociodemographics: not stated
Inclusion criteria
  1. ADHD according to DSM‐IV

  2. Teacher and Parent ADHD Rating Scale (Dupau, 1991) > 20

  3. Patient from the outpatient department of integrative medicine in paediatrics, Provincial Hospital Affiliated to Shandong University and the department of Neurology, Tongji Hospital of Huazhong University of Science and Technology


Exclusion criteria
  1. Taken anti‐ADHD medication prior to study

  2. Chronic medical condition including past history of cardiovascular disease, organic brain disorder, seizures

  3. Current abuse or dependence on drugs within 6 months

Interventions Methylphenidate type: not stated
Mean methylphenidate dosage: 1 mg/kg/day
Administration schedule: not stated
Duration of intervention: 8 weeks
Treatment compliance: not stated
Outcomes Serious adverse events:
  • Side effects were systematically recorded and assessed using a checklist by the psychiatrist or parents anytime during the study

  • No serious adverse effects were reported during the study


Non‐serious adverse events:
  • Blood was collected at the beginning and end of the trial

  • No abnormal findings were observed in the blood, urine and stool routine tests

Notes Sample calculation: no
Ethics approval: all research procedures were permitted by the medical ethics committee of Provincial Hospital Affiliated to Shandong University
Funding/vested interests: grants from the Chinese Medicine Administration Bureau of Shandong Province
Authors' affiliations: not stated
Key conclusions of the study authors: compared to methylphenidate, Ningdong granule is effective and safe for ADHD children in the short term, increases the homovanillic acid concentration in sera to regulate dopamine metabolism, and promises to be an alternative medication, safely and effectively
Exclusion of methylphenidate non‐responders/children who have previously experienced adverse events on methylphenidate: no
Supplemental information received through personal email correspondence with the study authors in April 2013 (Li 2013 [pers comm])